From the Y-ME Media Room (Highlights from SABC 2005) "The opening plenary session laid the groundwork for the meeting by discussing guidelines for patient care. Martine Piccart-Gebhart, M.D., Ph.D., from Belgium, emphasized that average treatment options apply to patients in general. It is important to translate those options into their implications for the individual patient. The Oncotype DX® genetic test was an example of the movement toward identifying characteristics that will allow treatments to be more tailored to biomarkers and the individual patient rather than be “one-size-fits-all therapies.” This section includes various abstracts and articles on issues of interest to the patient/advocate population. Abstract 3083 San Antonio BCa Symposium, 2005 Remember we are NOT Doctors and have NO medical training. This site is like an Encylopedia - there are many pages, many links on many topics. Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM.